Since therapeutic intervention with anti-oxidants has been shown to be effective in a unilateral ureteral ligation (UUO) model [28] and remnant kidney models [29,30], it is presumed that HSA-Trx ameliorates the AKI to CKD transition by suppressing oxidative stress in renal tissue. The gene discussed is TXN; the disease is chronic kidney disease.